Home / Taiwan Excellence Award / Award Winning Products / Product Details

About aetherAI Co., Ltd.

Asia’s leading medical image AI solution provider, aetherAI is dedicated to cutting-edge solutions for digital pathology transformation, AI-powered diagnostic support systems, and biopharma enterprise services. By leveraging state-of-the-art technologies, aetherAI aims to ease the burden on healthcare professionals and improve diagnostic imaging quality. At the forefront of digital pathology AI, aetherAI has partnered with top medical centers in the US, Taiwan, and Japan, including UPMC, National Taiwan University Hospital, Kanazawa University, etc. aetherAI is also a trusted collaborator for such BioPharma companies as Novartis Taiwan and ACT Genomics, and many more to accelerate AI applications for research efficiency.

https://www.aetherai.com/

Pathology is the study of disease. Until recent years, the traditional practice of pathology has remained unchanged over its 150-year history. This traditional practice is not only manual, but is prone to inaccuracy, error, and inefficiency. When aetherAI Co-founder & CEO Joe Yeh, M.D. went to the University of Southern California for the Ph.D. program in pathology, he was inspired by the power of computer algorithms to perform fast and accurate image analysis and its potential to improve healthcare. Thus Yeh left academia and founded aetherAI. Since then aetherAI has aimed to provide solutions for digital pathology and AI-powered diagnostic support to help pathologists perform more effectively with insights, realizing the true potential of the digital transformation.